Resiliencia y Mecanismos de Defensa en Pacientes con Cáncer en Quimioterapia Ambulatorial
| Autor: | Santos, Júlia Mariá Azambuja, Lorenzzoni, Ana Maria Vieira, Tigre, Aline, Heldt, Elizeth |
|---|---|
| Jazyk: | portugalština |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Revista Brasileira de Cancerologia; Vol. 68 No. 1 (2022): Jan./Feb./Mar.; e-131557 Revista Brasileira de Cancerologia; Vol. 68 Núm. 1 (2022): ene./feb./mar.; e-131557 Revista Brasileira de Cancerologia; v. 68 n. 1 (2022): jan./fev./mar.; e-131557 Revista Brasileira de Cancerologia Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
| ISSN: | 2176-9745 |
| Popis: | Introduction: The ability to cope with adverse situations, defined as resilience, helps patients to overcome difficulties in their treatment. However, there are still few studies assessing resilience in cancer patients undergoing outpatient chemotherapy. Objective: To assess resilience in cancer patients undergoing outpatient chemotherapy and to verify its correlation with defense mechanisms, as well as with symptoms of depression and anxiety. Method: Observational, correlational and prospective study with patients of both sexes, diagnosed with cancer, over 18 years old, literate and beginning treatment with outpatient chemotherapy. The following instruments were applied on the first day of chemotherapy treatment and then again after 30 to 45 days: Resilience Scale, Defense Style Questionnaire (DSQ-40), Beck’s Depression Inventory and Beck’s Anxiety Inventory. Results: A total of 55 participants were included in the study, 32 (58%) of which were female, with an average age and standard deviation (SD) of 54.1 (SD=12.2) years. The most frequent diagnoses were colorectal cancer, 15 (27%) and breast cancer, 12 (22%). There was a significant negative correlation between symptoms of depression or anxiety and resilience levels both in the first (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|